Levofloxacin (oral): Difference between revisions
No edit summary |
No edit summary |
||
| Line 24: | Line 24: | ||
'''| [[Levofloxacin indications and usage|Indications and Usage]]''' | '''| [[Levofloxacin indications and usage|Indications and Usage]]''' | ||
'''| [[Levofloxacin contraindications|Contraindications]]''' | '''| [[Levofloxacin contraindications|Contraindications]]''' | ||
'''| [[Levofloxacin warnings|Warnings | '''| [[Levofloxacin warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[Levofloxacin adverse reactions|Adverse Reactions]]''' | '''| [[Levofloxacin adverse reactions|Adverse Reactions]]''' | ||
'''| [[Levofloxacin overdosage|Overdosage]]''' | '''| [[Levofloxacin overdosage|Overdosage]]''' | ||
Revision as of 07:32, 9 January 2014
Template:Levofloxacin Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
For patient information, click here.
Overview
Levofloxacin (trade names Levaquin (US), Tavanic (EU), and others) is a broad spectrum antibiotic of the fluoroquinolone drug class, and the levo isomer of its predecessor ofloxacin. Its spectrum of activity includes most strains of bacterial pathogens responsible for respiratory, urinary tract, gastrointestinal, and abdominal infections.
Category
Fluoroquinolone, third generation.
US Brand Names
LEVAQUIN®, LEVOFLOXACIN®.
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages